Orbusneich
Clinical trials sponsored by Orbusneich, explained in plain language.
-
New balloon coated with drug aims to keep leg arteries open longer
Disease control OngoingThis study follows 284 people with blocked leg arteries (peripheral arterial disease) who are treated with a paclitaxel-coated balloon. The balloon is inflated inside the artery to open it and release a drug that helps prevent it from narrowing again. Researchers are tracking saf…
Sponsor: OrbusNeich • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New Drug-Coated stent tested for clogged heart arteries
Disease control OngoingThis study is tracking 251 patients with symptomatic coronary heart disease who received the EucaLimus stent, a sirolimus-coated device designed to keep arteries open. The goal is to see how well the stent works and how safe it is over the long term in real-world use. Researchers…
Sponsor: OrbusNeich • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Drug-Coated balloon for clogged arteries under Long-Term review
Disease control OngoingThis study is tracking 282 patients with coronary artery disease who received a paclitaxel-coated balloon catheter (Support C DCB) during routine care. Researchers are monitoring for heart-related events like cardiac death, heart attack, or the need for repeat procedures over the…
Sponsor: OrbusNeich • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC